Subcutaneous Epcoritamab Combined With R-CHOP for First-Line Treatment of Patients With High-Risk Diffuse Large B-Cell Lymphoma: Phase 1/2 Update

F Lorenzo; O Fritz; B David; B Joshua; KM Linton; K Yasmin; C Raul; S Sylvia; A Aqeel; W Liwei; W Jun; E Brian; MR Clausen

Subcutaneous Epcoritamab Combined With R-CHOP for First-Line Treatment of Patients With High-Risk Diffuse Large B-Cell Lymphoma: Phase 1/2 Update

F Lorenzo, O Fritz, B David, B Joshua, KM Linton, K Yasmin, C Raul, S Sylvia, A Aqeel, W Liwei, W Jun, E Brian, MR Clausen

Division of Cancer Sciences (L5)

Research output: Contribution to journal › Meeting Abstract › peer-review

Original language	English
Pages (from-to)	S30-S30
Number of pages	1
Journal	American Journal of Hematology
Volume	97
Publication status	Published - Oct 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{fb46996bf26948abbe27103a67aebec1,

title = "Subcutaneous Epcoritamab Combined With R-CHOP for First-Line Treatment of Patients With High-Risk Diffuse Large B-Cell Lymphoma: Phase 1/2 Update",

author = "F Lorenzo and O Fritz and B David and B Joshua and KM Linton and K Yasmin and C Raul and S Sylvia and A Aqeel and W Liwei and W Jun and E Brian and MR Clausen",

year = "2022",

month = oct,

language = "English",

volume = "97",

pages = "S30--S30",

journal = "American Journal of Hematology",

issn = "0361-8609",

publisher = "John Wiley & Sons Ltd",

}

TY - JOUR

T1 - Subcutaneous Epcoritamab Combined With R-CHOP for First-Line Treatment of Patients With High-Risk Diffuse Large B-Cell Lymphoma

T2 - Phase 1/2 Update

AU - Lorenzo, F

AU - Fritz, O

AU - David, B

AU - Joshua, B

AU - Linton, KM

AU - Yasmin, K

AU - Raul, C

AU - Sylvia, S

AU - Aqeel, A

AU - Liwei, W

AU - Jun, W

AU - Brian, E

AU - Clausen, MR

PY - 2022/10

Y1 - 2022/10

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pure_starter&SrcAuth=WosAPI&KeyUT=WOS:000866743000050&DestLinkType=FullRecord&DestApp=WOS

M3 - Meeting Abstract

SN - 0361-8609

VL - 97

SP - S30-S30

JO - American Journal of Hematology

JF - American Journal of Hematology

ER -

Subcutaneous Epcoritamab Combined With R-CHOP for First-Line Treatment of Patients With High-Risk Diffuse Large B-Cell Lymphoma: Phase 1/2 Update

UN SDGs

Other files and links

Cite this